American Society of Hirudotherapy

C-terminal peptide alcohol, acid and amide analogs of desulfato hirudin54-65 as antithrombin agents

Research article published in Thrombosis research (1989)

Last Updated: June 18, 2026Reviewed by: ASH Editorial Board
Research article — evidence reviewArticle reference
Evidence: Research reportDrug DevelopmentKrstenansky JL et al. · Thrombosis research, 1989

Abstract

Analogs of the antithrombin peptide hirudin54-65 with C-terminal modifications have been synthesized in order to examine the requirements for alpha-thrombin inhibition. The C-terminal residue, Gln65, could be replaced with L-amino acids or amino alcohols with neutral or charged hydrophilic side chains without greatly affecting the peptide's antithrombin potency as determined by inhibition of thrombin-induced clot formation in human plasma in vitro. Derivatives with D- or L-amino carboxamides at position 65 had significantly reduced potency, but still retained activity. Deletion of residue 65 with conversion of residue 64 to the amide or alcohol derivative resulted in a three-fold loss of potency. In addition to these results the solid-phase synthesis of peptide alcohols via direct displacement of p-nitrobenzhydrylideneisonitroso resin attached peptides with the desired C-terminal amino alcohol is reported.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeJournal Article
Indexed MeSH termsAcidsAlcoholsAmidesAntithrombinsFemaleFibrinHirudinsHumansIn Vitro TechniquesPeptides

Summary

Analogs of the antithrombin peptide hirudin54-65 with C-terminal modifications have been synthesized in order to examine the requirements for alpha-thrombin inhibition.

Why This Matters for Hirudotherapy

This study synthesized C-terminal analogs of the antithrombin peptide hirudin54-65 with modifications at position 65 to examine the structural requirements for alpha-thrombin inhibition, measuring potency by inhibition of thrombin-induced clot formation in human plasma in vitro. Replacement of the C-terminal residue with L-amino acids or amino alcohols having neutral or charged hydrophilic side chains did not greatly affect antithrombin potency, whereas derivatives with D- or L-amino carboxamides at position 65 showed significantly reduced but retained activity; deletion of residue 65 produced a three-fold loss of potency. Because the abstract explicitly names hirudin54-65 as the parent peptide, the work has a defensible biochemical relevance to ASH's domain as a structure-activity study of a hirudin fragment. However, the abstract makes no mention of leeches, leech saliva, leech secretome, or hirudotherapy, and the study is purely in vitro.

Citation

C-terminal peptide alcohol, acid and amide analogs of desulfato hirudin54-65 as antithrombin agents

Krstenansky JL et al. · Thrombosis research, 1989

Added to ASH library: May 27, 2026 · Site last updated: June 18, 2026

This website provides educational information and does not constitute medical advice, diagnosis, or treatment recommendations. Medicinal leech therapy carries clinically meaningful risks and should be performed only by qualified clinicians under institutionally approved protocols. FDA 510(k) clearance for medicinal leeches is limited to specific indications; investigational and off-label discussions are labeled accordingly. For patient-specific guidance, consult a qualified healthcare provider.